Department of Medicine, 12223Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Medicine, 12244Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Prog Transplant. 2022 Dec;32(4):274-282. doi: 10.1177/15269248221122872.
The growing practice of living liver donation requires comprehensive understanding of the financial implications for living liver donors. While obtaining and maintaining insurance is important to financial health, little is known about the impact of liver donation on future insurability.
The purpose of this study was to evaluate the donors' experiences with insurance following donation and identify the insurance provider-driven factors that contribute to donor insurability.
A two center cohort of living donors with donation between January 2000 and December 2018 (N = 442) were surveyed about postdonation insurance experiences. To understand insurance provider practices towards liver donors, life (n = 11) and disability (n = 4) insurance underwriters were asked to provide policy quotes for a standardized living liver donor profile.
Responses (N = 101) were received by August 2020 (response rate = 22.9%). Living liver donors reported owning life (58%), disability (35%), and medical (87%) insurance at rates comparable to the general population with low proportions reporting difficulty obtaining these insurance types (9%, 9%, 4%, respectively). Post-donation life insurance ownership was associated with post-donation employment (P = 0.01). Underwriter responses indicate life and disability insurability were adversely affected up to 12 months following donation.
Living liver donors did not have difficulty maintaining insurance in the long-term but should be counseled to purchase insurance prior to surgery as short-term insurability may be affected. Perception of difficulty obtaining insurance following donation remains of significant concern among living donors. Further collaboration between the transplant community and insurance companies is warranted.
活体肝移植的实践日益增多,因此需要全面了解活体肝供者的经济影响。获得和维持保险对财务健康很重要,但对于肝移植对未来可保性的影响知之甚少。
本研究的目的是评估供者在捐赠后的保险经历,并确定导致供者可保性的保险提供商相关因素。
对 2000 年 1 月至 2018 年 12 月期间进行活体捐赠的两个中心队列的供者进行了调查,以了解其捐赠后的保险经历。为了了解保险公司对活体肝供者的实践,向人寿(n=11)和残疾(n=4)保险核保人询问了为标准化活体肝供者提供的保险报价。
2020 年 8 月收到回复(回复率为 22.9%)。活体肝供者报告拥有人寿保险(58%)、残疾保险(35%)和医疗保险(87%)的比例与一般人群相当,报告难以获得这些保险类型的比例较低(分别为 9%、9%和 4%)。捐赠后人寿保险的拥有与捐赠后就业有关(P=0.01)。核保人的回复表明,捐赠后 12 个月内,人寿保险和残疾保险的可保性受到不利影响。
活体肝供者在长期内维持保险并不困难,但应在手术前购买保险,因为短期可保性可能会受到影响。供者在捐赠后获得保险存在困难的认知仍然是一个重要问题。需要进一步在移植社区和保险公司之间进行合作。